A detailed history of Beck Bode, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Beck Bode, LLC holds 2,876 shares of ILMN stock, worth $388,403. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,876
Holding current value
$388,403
% of portfolio
0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$105.28 - $135.9 $302,785 - $390,848
2,876 New
2,876 $375,000
Q3 2019

Dec 02, 2019

SELL
$266.84 - $378.23 $7.17 Million - $10.2 Million
-26,880 Closed
0 $0
Q2 2019

Nov 27, 2019

BUY
$300.59 - $368.15 $208,609 - $255,496
694 Added 2.65%
26,880 $9.9 Million
Q1 2019

Nov 27, 2019

BUY
$272.57 - $321.18 $82,861 - $97,638
304 Added 1.17%
26,186 $8.14 Million
Q4 2018

Nov 27, 2019

BUY
$272.46 - $366.54 $7.05 Million - $9.49 Million
25,882 New
25,882 $7.76 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.2B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Beck Bode, LLC Portfolio

Follow Beck Bode, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Bode, LLC with notifications on news.